Cargando…
Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study
Corticosteroid is commonly used to reduce damage from inflammatory reactions in coronavirus disease 2019 (COVID-19). We aim to determine the outcomes of corticosteroid use in critically ill COVID-19 patients. Ninety six critically ill patients, hospitalized in 14 hospitals outside Wuhan from January...
Autores principales: | Li, Yichen, Li, Jie, Ke, Jia, Jiao, Na, Zhu, Lixin, Shen, Lihan, Chen, Lei, Jiang, Zhiqiang, Cheng, Sijing, Huang, Yibo, Zou, Yifeng, Zhu, Ruixin, Yan, Guangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900536/ https://www.ncbi.nlm.nih.gov/pubmed/33634148 http://dx.doi.org/10.3389/fmed.2021.604263 |
Ejemplares similares
-
Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study
por: Cheng, Sijing, et al.
Publicado: (2020) -
Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study
por: Li, Yichen, et al.
Publicado: (2020) -
Gastrointestinal sequelae 90 days after discharge for COVID-19
por: Weng, Jingrong, et al.
Publicado: (2021) -
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan
por: Wan, Yunle, et al.
Publicado: (2020) -
The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases
por: Li, Yichen, et al.
Publicado: (2022)